Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Extension of use of isomalto-oligosaccharide as a novel food pursuant to Regulation (EU) 2015/2283

EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) et al. EFSA J. .

Abstract

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the extension of use of isomalto-oligosaccharide (IMO) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF consists of glucose oligomers with degrees of polymerisation of 3-9, along with various amounts of mono- and disaccharides. The NF comes in both syrup and powder form. The applicant intends to extend the current uses of the NF as an ingredient in several foods, and use the NF in food supplements aimed at the general population older than 10 years of age. The information provided on the manufacturing process, composition and specifications of the NF is sufficient and does not raise safety concerns. Along with literature data, the applicant carried out a tolerability study in adult volunteers with the NF at doses up to 120 g/day. The Panel concludes that this study provides reassurance that the NF is tolerable at doses of 120 g/day. Conservative intake estimates resulting from the use of the NF as an ingredient according to the currently authorised uses and new proposed uses result in a highest intake estimate in adolescents of 112 g/day at the 95th percentile, and reach 142 g/day in adolescents when the use as a food supplement is included. The Panel notes this amount is higher than the dose of 120 g/day for which tolerability has been demonstrated. However, considering the source, compositional characterisation, production process and nature of the NF, as well as the available nutritional and toxicological data on the NF, the Panel considers that the NF does not present safety concerns under the proposed conditions of use.

Keywords: IMO; extension of use; food supplement; isomalto‐oligosaccharide; novel foods.

PubMed Disclaimer

Conflict of interest statement

If you wish to access the declaration of interests of any expert contributing to an EFSA scientific assessment, please contact interestmanagement@efsa.europa.eu.

Figures

FIGURE 1
FIGURE 1
Summary of the manufacturing process of IMO.
See this image and copyright information in PMC

References

    1. Bouhnik, Y. , Raskine, L. , Simoneau, G. , Vicaut, E. , Neut, C. , Flourie, B. , Brouns, F. , & Bornet, F. R. (2004). The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double‐blind, randomized, placebo‐controlled, parallel‐group, dose‐response relation study. The American Journal of Clinical Nutrition, 80(6), 1658–1664. 10.1093/ajcn/80.6.1658 - DOI - PubMed
    1. Chen, H. L. , Lu, Y. H. , Lin, J. J. , & Ko, L. Y. (2001). Effects of isomalto‐oligosaccharides on bowel functions and indicators of nutritional status in constipated elderly men. Journal of the American College of Nutrition, 20(1), 44–49. 10.1080/07315724.2001.10719013 - DOI - PubMed
    1. Dimenas, E. , Carlsson, G. , Glise, H. , Israelsson, B. , & Wiklund, I. (1996). Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scandinavian Journal of Gastroenterology, 31, 8–13. 10.3109/00365529609095544 - DOI - PubMed
    1. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies) , Turck, D. , Bresson, J.‐L. , Burlingame, B. , Dean, T. , Fairweather‐Tait, S. , Heinonen, M. , Hirsch‐Ernst, K. I. , Mangelsdorf, I. , McArdle, H. , Naska, A. , Neuhäuser‐Berthold, M. , Nowicka, G. , Pentieva, K. , Sanz, Y. , Siani, A. , Sjödin, A. , Stern, M. , Tomé, D. , … van Loveren, H. (2016). Guidance on the preparation and presentation of an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283. EFSA Journal, 14(11), e04594. 10.2903/j.efsa.2016.4594 - DOI
    1. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies) . (2010). Scientific opinion on dietary reference values for carbohydrates and dietary fibre. EFSA Journal, 8(3), 1462. 10.2903/j.efsa.2010.1462 - DOI

LinkOut - more resources